Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	Fc-gamma receptor I complex binding	FLNA IGHG3 IGHG4	4.60e-06	7	103	3	GO:0034988
GeneOntologyMolecularFunction	protein-containing complex destabilizing activity	NSF KATNA1 CLPB	5.80e-05	15	103	3	GO:0140776
GeneOntologyMolecularFunction	adenosine-phosphate deaminase activity	AMPD1 AMPD3	7.88e-05	3	103	2	GO:0047623
GeneOntologyMolecularFunction	AMP deaminase activity	AMPD1 AMPD3	7.88e-05	3	103	2	GO:0003876
GeneOntologyMolecularFunction	immunoglobulin receptor binding	FLNA IGHG3 IGHG4	1.66e-04	21	103	3	GO:0034987
GeneOntologyMolecularFunction	ATP-dependent protein disaggregase activity	NSF CLPB	3.90e-04	6	103	2	GO:0140545
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	ZGRF1 SMARCAD1 CHD6 DSCC1 TOP2B	5.12e-04	127	103	5	GO:0008094
GeneOntologyBiologicalProcess	neuron migration	FLNA VAX1 NEXMIF DAB1 KATNA1 NRP1 KIRREL3 TOP2B	1.70e-05	218	106	8	GO:0001764
GeneOntologyBiologicalProcess	negative regulation of neuron projection development	FLNA DAB1 KATNA1 ACTR3 NRP1 INPP5J DYNC1I2	2.70e-05	169	106	7	GO:0010977
GeneOntologyBiologicalProcess	sister chromatid segregation	FLNA SMC2 PBRM1 NDC80 ANAPC5 GEN1 TOP2B ANAPC4	5.05e-05	254	106	8	GO:0000819
GeneOntologyBiologicalProcess	B cell receptor signaling pathway	TEC BLK CD22 IGHG3 IGHG4	5.43e-05	79	106	5	GO:0050853
GeneOntologyBiologicalProcess	regulation of chromosome segregation	SMC2 PBRM1 NDC80 ANAPC5 GEN1 ANAPC4	8.25e-05	139	106	6	GO:0051983
GeneOntologyBiologicalProcess	chromosome separation	SMARCAD1 SMC2 NDC80 ANAPC5 GEN1	9.10e-05	88	106	5	GO:0051304
GeneOntologyBiologicalProcess	nuclear chromosome segregation	FLNA SMC2 ACTR3 PBRM1 NDC80 ANAPC5 GEN1 TOP2B ANAPC4	9.27e-05	356	106	9	GO:0098813
GeneOntologyBiologicalProcess	sexual reproduction	UNC13B CFAP47 FOXO3 TDRD5 SLC26A3 SMC2 YTHDC1 PKDREJ ACTR3 ADGB USP26 NDC80 KAT8 MEIOSIN C2CD6 ANAPC5 TOP2B ANAPC4	1.19e-04	1312	106	18	GO:0019953
GeneOntologyBiologicalProcess	regulation of mitotic metaphase/anaphase transition	PBRM1 NDC80 ANAPC5 GEN1 ANAPC4	1.31e-04	95	106	5	GO:0030071
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	FLNA FMR1 ANK3 SPTAN1 DAB1 KATNA1 ACTR3 NRP1 PPARGC1A TBC1D4 NDC80 GEN1 INPP5J DYNC1I2	1.36e-04	864	106	14	GO:0051129
GeneOntologyBiologicalProcess	chromosome segregation	FLNA SMARCAD1 SMC2 ACTR3 PBRM1 NDC80 ANAPC5 GEN1 TOP2B ANAPC4	1.42e-04	465	106	10	GO:0007059
GeneOntologyBiologicalProcess	regulation of metaphase/anaphase transition of cell cycle	PBRM1 NDC80 ANAPC5 GEN1 ANAPC4	1.52e-04	98	106	5	GO:1902099
GeneOntologyBiologicalProcess	metaphase/anaphase transition of mitotic cell cycle	PBRM1 NDC80 ANAPC5 GEN1 ANAPC4	1.67e-04	100	106	5	GO:0007091
GeneOntologyBiologicalProcess	purine-containing compound salvage	AMPD1 AMPD3 PGM2	1.89e-04	22	106	3	GO:0043101
GeneOntologyBiologicalProcess	metaphase/anaphase transition of cell cycle	PBRM1 NDC80 ANAPC5 GEN1 ANAPC4	1.91e-04	103	106	5	GO:0044784
GeneOntologyBiologicalProcess	negative regulation of cell projection organization	FLNA DAB1 KATNA1 ACTR3 NRP1 INPP5J DYNC1I2	2.03e-04	233	106	7	GO:0031345
GeneOntologyBiologicalProcess	positive regulation of blood-brain barrier permeability	TJP2 OCLN	2.59e-04	5	106	2	GO:1905605
GeneOntologyBiologicalProcess	regulation of sister chromatid segregation	PBRM1 NDC80 ANAPC5 GEN1 ANAPC4	2.71e-04	111	106	5	GO:0033045
GeneOntologyBiologicalProcess	microtubule-based process	CFAP47 FLNA FMR1 ANK3 KATNA1 ACTR3 NDC80 NISCH VPS13A C2CD6 OCLN GEN1 ARHGAP21 INPP5J DYNC1I2	3.29e-04	1058	106	15	GO:0007017
GeneOntologyCellularComponent	basal ectoplasmic specialization	ACTR3 KIAA1210	7.76e-05	3	107	2	GO:0061832
GeneOntologyCellularComponent	anchoring junction	FLNA ANK3 CDHR2 SPTAN1 TEC ACTR3 NRP1 KIAA1210 KIRREL3 FAT1 SH3PXD2A TJP2 ADGRE5 OCLN ARHGAP21	1.33e-04	976	107	15	GO:0070161
GeneOntologyCellularComponent	9+2 motile cilium	SLC26A3 ADGB USP26 RSPH10B2 VPS13A C2CD6 RSPH10B	2.25e-04	238	107	7	GO:0097729
GeneOntologyCellularComponent	motile cilium	CFAP47 SLC26A3 ADGB USP26 RSPH10B2 VPS13A C2CD6 RSPH10B	4.84e-04	355	107	8	GO:0031514
GeneOntologyCellularComponent	dendritic shaft	FLNA NSF KIRREL3 INPP5J	5.67e-04	74	107	4	GO:0043198
MousePheno	decreased memory B cell number	CD22 IGHG3 IGHG4	2.33e-05	9	93	3	MP:0008729
MousePheno	abnormal memory B cell number	CD22 IGHG3 IGHG4	4.53e-05	11	93	3	MP:0008093
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	PAG1 ACACB ANK3 PLEKHA6 FCHO2 RAB11FIP1 NISCH ITSN2 OCLN ARHGAP21	8.92e-07	421	109	10	36976175
Pubmed	The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.	IGHG3 IGHG4 SDC1	1.66e-06	8	109	3	18542049
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	FLNA PAG1 ANK3 SPTAN1 PLEKHA6 SCEL TJP2 N4BP1 OCLN ARHGAP21 TPD52	1.72e-06	565	109	11	25468996
Pubmed	Global proteomics of Ubqln2-based murine models of ALS.	FLNA RIPK1 SPTAN1 FCHO2 ITSN2 N4BP1 OCLN DYNC1I2	1.79e-06	261	109	8	33277362
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	FLNA ZC3H13 PLEKHA6 FCHO2 RAB11FIP1 YTHDC1 PBRM1 TBC1D4 OSBPL11 TJP2	4.35e-06	503	109	10	16964243
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B SMARCAD1 USP19 KIRREL3 NISCH ITSN2 DZIP3 CHD6 ARHGAP21	5.73e-06	407	109	9	12693553
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FLNA ZC3H13 SPTAN1 SMARCAD1 YTHDC1 USP19 TBC1D4 OSBPL11 TJP2 ANAPC5 TOP2B DYNC1I2	5.92e-06	774	109	12	15302935
Pubmed	RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative phosphorylation and glycolysis.	RIPK1 PPARGC1A	9.73e-06	2	109	2	24583643
Pubmed	The RNA Binding Proteins YTHDC1 and FMRP Regulate the Nuclear Export of N6-Methyladenosine-Modified Hepatitis B Virus Transcripts and Affect the Viral Life Cycle.	FMR1 YTHDC1	9.73e-06	2	109	2	33883220
Pubmed	The Fragile X Mental Retardation Protein Regulates RIPK1 and Colorectal Cancer Resistance to Necroptosis.	FMR1 RIPK1	9.73e-06	2	109	2	33091622
Pubmed	In vitro protein complex formation with cytoskeleton-anchoring domain of occludin identified by limited proteolysis.	TJP2 OCLN	9.73e-06	2	109	2	14512431
Pubmed	Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes.	FOXO3 PPARGC1A	9.73e-06	2	109	2	19324885
Pubmed	PGC-1α promotes nitric oxide antioxidant defenses and inhibits FOXO signaling against cardiac cachexia in mice.	FOXO3 PPARGC1A	9.73e-06	2	109	2	21435455
Pubmed	[AMPD genes and urate metabolism].	AMPD1 AMPD3	9.73e-06	2	109	2	18409530
Pubmed	N-terminal sequence and distal histidine residues are responsible for pH-regulated cytoplasmic membrane binding of human AMP deaminase isoform E.	AMPD1 AMPD3	9.73e-06	2	109	2	12213808
Pubmed	Inactivation of Foxo3a and subsequent downregulation of PGC-1 alpha mediate nitric oxide-induced endothelial cell migration.	FOXO3 PPARGC1A	9.73e-06	2	109	2	20547753
Pubmed	The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover.	FLNA NRP1	9.73e-06	2	109	2	24021649
Pubmed	Peroxisome proliferator-activated receptor γ coactivator 1α and FoxO3A mediate chondroprotection by AMP-activated protein kinase.	FOXO3 PPARGC1A	9.73e-06	2	109	2	25047750
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	UNC13B ZNF140 ANK3 ZC3H13 KATNA1 YTHDC1 FAT1 TJP2	1.90e-05	361	109	8	26167880
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	FMR1 SPTAN1 FCHO2 PBRM1 CLPB DZIP3 CHD6 TOP2B INPP5J	1.96e-05	475	109	9	31040226
Pubmed	Characterization of the interaction between protein 4.1R and ZO-2. A possible link between the tight junction and the actin cytoskeleton.	SPTAN1 TJP2	2.91e-05	3	109	2	10874042
Pubmed	Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice.	FOXO3 PPARGC1A	2.91e-05	3	109	2	19730740
Pubmed	Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons.	AMPD1 AMPD3	2.91e-05	3	109	2	1400401
Pubmed	Platelet AMP deaminase. Purification and kinetic studies.	AMPD1 AMPD3	2.91e-05	3	109	2	7287721
Pubmed	Faster lipid β-oxidation rate by acetyl-CoA carboxylase 2 inhibition alleviates high-glucose-induced insulin resistance via SIRT1/PGC-1α in human podocytes.	ACACB PPARGC1A	2.91e-05	3	109	2	33957017
Pubmed	Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms.	AMPD1 AMPD3	2.91e-05	3	109	2	9857047
Pubmed	Evidence for a common mechanism of SIRT1 regulation by allosteric activators.	FOXO3 PPARGC1A	2.91e-05	3	109	2	23471411
Pubmed	The specific fates of tight junction proteins in apoptotic epithelial cells.	TJP2 OCLN	2.91e-05	3	109	2	15054114
Pubmed	FOXO3a-driven miRNA signatures suppresses VEGF-A/NRP1 signaling and breast cancer metastasis.	FOXO3 NRP1	2.91e-05	3	109	2	33262463
Pubmed	HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia.	TJP2 OCLN	2.91e-05	3	109	2	15977641
Pubmed	The BAH domain of BAF180 is required for PCNA ubiquitination.	PBRM1 USP1	2.91e-05	3	109	2	26117423
Pubmed	Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.	BARD1 SMARCAD1	2.91e-05	3	109	2	27239795
Pubmed	A novel dipeptide from potato protein hydrolysate augments the effects of exercise training against high-fat diet-induced damages in senescence-accelerated mouse-prone 8 by boosting pAMPK / SIRT1/ PGC-1α/ pFOXO3 pathway.	FOXO3 PPARGC1A	2.91e-05	3	109	2	32335547
Pubmed	Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA.	AMPD1 AMPD3	2.91e-05	3	109	2	1429593
Pubmed	Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.	UNC13B NSF	2.91e-05	3	109	2	21812969
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	PAG1 RIPK1 AFF3 COL5A3 TEC BLK CLPB SH3PXD2A STK33 ANAPC5 ARHGAP21 ANAPC4	2.94e-05	910	109	12	36736316
Pubmed	CASK deletion in intestinal epithelia causes mislocalization of LIN7C and the DLG1/Scrib polarity complex without affecting cell polarity.	SPTAN1 OCLN SDC1	3.28e-05	20	109	3	19726564
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	FMR1 SMARCAD1 SMC2 NRP1 CEMIP PARP4 NISCH OSBPL11 ANAPC5 ARHGAP21	3.94e-05	650	109	10	38777146
Pubmed	Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain.	IGHG3 IGHG4	5.82e-05	4	109	2	113776
Pubmed	Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.	IGHG3 IGHG4	5.82e-05	4	109	2	11812141
Pubmed	Multiple amino acid substitutions between murine gamma 2a heavy chain Fc regions of Ig1a and Ig1b allotypic forms.	IGHG3 IGHG4	5.82e-05	4	109	2	6794027
Pubmed	The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton.	TJP2 OCLN	5.82e-05	4	109	2	9792688
Pubmed	Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes.	IGHG3 IGHG4	5.82e-05	4	109	2	2510996
Pubmed	Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection.	IGHG3 IGHG4	5.82e-05	4	109	2	1754385
Pubmed	Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies.	IGHG3 IGHG4	5.82e-05	4	109	2	19050247
Pubmed	An autoimmune disease variant of IgG1 modulates B cell activation and differentiation.	IGHG3 IGHG4	5.82e-05	4	109	2	30287618
Pubmed	Switch transcripts in immunoglobulin class switching.	IGHG3 IGHG4	5.82e-05	4	109	2	7892607
Pubmed	Determination of the primary structure of a mouse G2a immunoglobulin. Identification of the disulfide bridges.	IGHG3 IGHG4	5.82e-05	4	109	2	4565406
Pubmed	Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy.	FOXO3 PPARGC1A	5.82e-05	4	109	2	20404331
Pubmed	IgG1 protects against renal disease in a mouse model of cryoglobulinaemia.	IGHG3 IGHG4	5.82e-05	4	109	2	25363774
Pubmed	Mutational deglycosylation of the Fc portion of immunoglobulin G causes O-sulfation of tyrosine adjacently preceding the originally glycosylated site.	IGHG3 IGHG4	5.82e-05	4	109	2	20621099
Pubmed	Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).	IGHG3 IGHG4	5.82e-05	4	109	2	12414967
Pubmed	Dynamic assembly of tight junction-associated proteins ZO-1, ZO-2, ZO-3 and occludin during mouse tooth development.	TJP2 OCLN	5.82e-05	4	109	2	12507281
Pubmed	Shutdown of class switch recombination by deletion of a switch region control element.	IGHG3 IGHG4	5.82e-05	4	109	2	8438159
Pubmed	Passive anaphylaxis in mice with gamma-G antibodies. V. Competitive effects of different immunoglobulins and inhibition of reactions with antiglobulin sera.	IGHG3 IGHG4	5.82e-05	4	109	2	4098598
Pubmed	Mouse immunoglobulin genes: a bacterial plasmid containing the entire coding sequence for a pre-gamma 2a heavy chain.	IGHG3 IGHG4	5.82e-05	4	109	2	6253932
Pubmed	Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid.	IGHG3 IGHG4	5.82e-05	4	109	2	6769752
Pubmed	Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes.	IGHG3 IGHG4	5.82e-05	4	109	2	6803173
Pubmed	Linkage of the four gamma subclass heavy chain genes.	IGHG3 IGHG4	5.82e-05	4	109	2	6264445
Pubmed	Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells.	IGHG3 IGHG4	5.82e-05	4	109	2	2878362
Pubmed	IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice.	IGHG3 IGHG4	5.82e-05	4	109	2	25867470
Pubmed	Sequence of the gamma 2b membrane 3' untranslated region: polya site determination and comparison to the gamma 2a membrane 3' untranslated region.	IGHG3 IGHG4	5.82e-05	4	109	2	1542303
Pubmed	Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.	IGHG3 IGHG4	5.82e-05	4	109	2	9725203
Pubmed	Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains.	IGHG3 IGHG4	5.82e-05	4	109	2	9126488
Pubmed	The IL-4 induced increase in the frequency of resting murine splenic B cells expressing germline Ig heavy chain gamma 1 transcripts correlates with subsequent switching to IgG1.	IGHG3 IGHG4	5.82e-05	4	109	2	8452816
Pubmed	Determination of the primary structure of a mouse IgG2a immunoglobulin:amino-acid sequence of the Fc fragment. Implications for the evolution of immunoglobulin structure and function.	IGHG3 IGHG4	5.82e-05	4	109	2	4831970
Pubmed	Nucleotide sequences of class-switch recombination region of the mouse immunoglobulin gamma 2b-chain gene.	IGHG3 IGHG4	5.82e-05	4	109	2	7439686
Pubmed	On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed.	IGHG3 IGHG4	5.82e-05	4	109	2	6278424
Pubmed	An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment.	IGHG3 IGHG4	5.82e-05	4	109	2	35133976
Pubmed	Restriction fragment length polymorphism and evolution of the mouse immunoglobulin constant region gamma loci.	IGHG3 IGHG4	5.82e-05	4	109	2	8099342
Pubmed	Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin.	TJP2 OCLN	5.82e-05	4	109	2	10026224
Pubmed	Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation.	IGHG3 IGHG4	5.82e-05	4	109	2	32006024
Pubmed	Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries.	ANK3 PBRM1	5.82e-05	4	109	2	21037240
Pubmed	Strong antigenic selection shaping the immunoglobulin heavy chain repertoire of B-1a lymphocytes in lambda 2(315) transgenic mice.	IGHG3 IGHG4	5.82e-05	4	109	2	12209645
Pubmed	Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain.	IGHG3 IGHG4	5.82e-05	4	109	2	117549
Pubmed	Cloning immunoglobulin gamma 2b chain gene of mouse: characterization and partial sequence determination.	IGHG3 IGHG4	5.82e-05	4	109	2	116231
Pubmed	Tight junction protein ZO-2 expression and relative function of ZO-1 and ZO-2 during mouse blastocyst formation.	TJP2 OCLN	5.82e-05	4	109	2	18817772
Pubmed	Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a.	IGHG3 IGHG4	5.82e-05	4	109	2	25451975
Pubmed	Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains.	IGHG3 IGHG4	5.82e-05	4	109	2	6283537
Pubmed	Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain.	IGHG3 IGHG4	5.82e-05	4	109	2	6801765
Pubmed	Immunoglobulin diversity: analysis of the germ-line VH gene repertoire of the murine anti-GAT response.	IGHG3 IGHG4	5.82e-05	4	109	2	6306571
Pubmed	The molecular and biochemical characterization of mutant monoclonal antibodies with increased antigen binding.	IGHG3 IGHG4	5.82e-05	4	109	2	1672339
Pubmed	Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment.	IGHG3 IGHG4	5.82e-05	4	109	2	1713710
Pubmed	Structure of the constant and 3' untranslated regions of the murine Balb/c gamma 2a heavy chain messenger RNA.	IGHG3 IGHG4	5.82e-05	4	109	2	6777755
Pubmed	The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.	IGHG3 IGHG4	5.82e-05	4	109	2	9103199
Pubmed	Gene conversion and polymorphism: generation of mouse immunoglobulin gamma 2a chain alleles by differential gene conversion by gamma 2b chain gene.	IGHG3 IGHG4	5.82e-05	4	109	2	6297797
Pubmed	Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain.	IGHG3 IGHG4	5.82e-05	4	109	2	98524
Pubmed	Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy.	IGHG3 IGHG4	5.82e-05	4	109	2	38268239
Pubmed	Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains.	IGHG3 IGHG4	5.82e-05	4	109	2	6799207
Pubmed	Comparison of mouse immunoglobulin gamma 2a and gamma 2b chain genes suggests that exons can be exchanged between genes in a multigenic family.	IGHG3 IGHG4	5.82e-05	4	109	2	6787604
Pubmed	Reelin-Nrp1 Interaction Regulates Neocortical Dendrite Development in a Context-Specific Manner.	DAB1 NRP1	5.82e-05	4	109	2	33009002
Pubmed	CK2-dependent phosphorylation of occludin regulates the interaction with ZO-proteins and tight junction integrity.	TJP2 OCLN	5.82e-05	4	109	2	23758859
Pubmed	Multiple differences between the nucleic acid sequences of the IgG2aa and IgG2ab alleles of the mouse.	IGHG3 IGHG4	5.82e-05	4	109	2	6170065
Pubmed	BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ.	BARD1 TOP2B	5.82e-05	4	109	2	34610268
Pubmed	Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals.	IGHG3 IGHG4	5.82e-05	4	109	2	19703988
Pubmed	Resveratrol rescues cadmium-induced mitochondrial injury by enhancing transcriptional regulation of PGC-1α and SOD2 via the Sirt3/FoxO3a pathway in TCMK-1 cells.	FOXO3 PPARGC1A	5.82e-05	4	109	2	28286268
Pubmed	Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.	IGHG3 IGHG4	5.82e-05	4	109	2	6767246
Pubmed	Determination of the interface of a large protein complex by transferred cross-saturation measurements.	IGHG3 IGHG4	5.82e-05	4	109	2	12051834
Pubmed	The gamma 1 heavy chain gene includes all of the cis-acting elements necessary for expression of properly regulated germ-line transcripts.	IGHG3 IGHG4	5.82e-05	4	109	2	8683112
Pubmed	Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse.	IGHG3 IGHG4	5.82e-05	4	109	2	807855
Interaction	RHOA interactions	FLNA ANK3 NSF SPTAN1 RAB11FIP1 YTHDC1 NRP1 FAT1 CLPB PDP1 NISCH NUS1 VPS13A OSBPL11 TJP2 ADGRE5 OCLN ARHGAP21 TOP2B TPD52	3.27e-06	1199	105	20	int:RHOA
Interaction	RHOB interactions	PAG1 ANK3 NSF SPTAN1 FCHO2 RAB11FIP1 FAT1 NISCH NUS1 VPS13A OSBPL11 TJP2 ADGRE5 OCLN ARHGAP21 TOP2B	6.99e-06	840	105	16	int:RHOB
Interaction	OCLN interactions	UNC13B ANK3 SPTAN1 FCHO2 RAB11FIP1 NRP1 NISCH TJP2 ADGRE5 OCLN SDC1 ARHGAP21	1.15e-05	500	105	12	int:OCLN
Interaction	LYN interactions	PAG1 ANK3 SPTAN1 FCHO2 TEC RAB11FIP1 BLK CD22 NISCH VPS13A OSBPL11 OCLN ARHGAP21 TOP2B	2.21e-05	720	105	14	int:LYN
Interaction	DLG5 interactions	ANK3 ACTR3 NRP1 NDC80 TJP2 GAN OCLN	3.81e-05	176	105	7	int:DLG5
GeneFamily	Adenosine deaminase family	AMPD1 AMPD3	2.26e-04	6	71	2	1302
GeneFamily	AAA ATPases	NSF KATNA1 CLPB	1.18e-03	53	71	3	413
GeneFamily	Anaphase promoting complex \|Tetratricopeptide repeat domain containing	ANAPC5 ANAPC4	1.34e-03	14	71	2	402
GeneFamily	Ubiquitin specific peptidases	USP19 USP26 USP1	1.39e-03	56	71	3	366
GeneFamily	Cadherin related	CDHR2 FAT1	1.99e-03	17	71	2	24
Coexpression	LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM	UNC13B SLC26A3 ACACB ZC3H13 DAB1 PLEKHA6 YTHDC1 ZC3H6 NRP1 CHD6 TPD52 TMEM63A	1.29e-07	417	106	12	M39224
Coexpression	MURARO_PANCREAS_DUCTAL_CELL	FOXO3 FLNA ANK3 SPTAN1 CPA3 RAB11FIP1 ACTR3 NRP1 KRT23 PPARGC1A PARP4 FAT1 PDP1 TJP2 OCLN PGM2 SDC1 ARHGAP21 TOP2B DYNC1I2	1.72e-07	1276	106	20	M39173
Coexpression	GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP	SLC26A3 CDHR2 BARD1 ZC3H6 SYTL3 PDP1 ADGRE5 USP1	1.53e-06	199	106	8	M6395
Coexpression	PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	FMR1 ZGRF1 BARD1 OSBPL11 OCLN ANAPC5 GEN1	1.48e-05	195	106	7	M13736
Coexpression	GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP	SPTAN1 RAB11FIP1 KATNA1 MMP20 TBC1D4 CD22 OCLN	1.69e-05	199	106	7	M4444
Coexpression	HADDAD_B_LYMPHOCYTE_PROGENITOR	FMR1 BARD1 BLK CD22 VPS13A ANAPC5 TOP2B TPD52	2.41e-05	290	106	8	M939
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	ZGRF1 BARD1 SMC2 FAT1 NDC80 DSCC1 USP1 GEN1 SDC1	3.80e-05	402	106	9	MM454
Coexpression	YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP	SLC26A3 ZC3H13 L1TD1 IGHG3 IGHG4 STK33	4.69e-05	159	106	6	MM777
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 SCEL CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	1.82e-10	156	109	9	d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb
ToppCell	mild_COVID-19_(asymptomatic)-B_intermediate\|World / disease group, cell group and cell class (v2)	AFF3 BLK CD22 SH3PXD2A IGHG3 IGHG4 GEN1 TPD52	6.01e-09	160	109	8	6722934e153b72039c3c4308557d0ef879a30638
ToppCell	mild_COVID-19_(asymptomatic)-B_intermediate\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	AFF3 BLK CD22 SH3PXD2A IGHG3 IGHG4 GEN1 TPD52	8.02e-09	166	109	8	8de8f388f24436b84e19ef460476fdbda4d16abf
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	1.72e-08	183	109	8	ffa831f67ed005f05d1b80ebc707e046fc08e22f
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	1.72e-08	183	109	8	01664fce6b70a02c9d39d747b6a6aabc86d57bc2
ToppCell	Healthy_donor-B_memory\|World / disease group, cell group and cell class (v2)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.03e-08	187	109	8	4f68e3243071a4549c80aff8bff32c6ad892ee7f
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AMPD1 AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	2.12e-08	188	109	8	c3cae529fdbeb233d2b32bcc3537a8aba26a7dc2
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AMPD1 AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	2.30e-08	190	109	8	a21d0c574abf21e7cb865a21a48f29c92d055fbe
ToppCell	Control-Lymphoid_B-B_intermediate\|Control / Disease group, lineage and cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.40e-08	191	109	8	0082181dbc39c7c4fd3aa34c3ed61439548e844b
ToppCell	B_cells\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	AFF3 RAB11FIP1 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	2.40e-08	191	109	8	72e3191990973440e4f91427208df360f73e4f41
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.50e-08	192	109	8	f9f64ad7bab1433e9a45adb7db7f43ce3f591b47
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.50e-08	192	109	8	4884fd8ffa6fd6c30d7ac6bf447456b3397eabc5
ToppCell	Healthy/Control-B_intermediate\|World / Disease group and Cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.50e-08	192	109	8	2266aa695955f5d885708e6bc0d5a8827c306223
ToppCell	Healthy_donor-B_intermediate\|World / disease group, cell group and cell class (v2)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.50e-08	192	109	8	f77007b284e11f8654ad599eef929df7c6c4ebf0
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.60e-08	193	109	8	8f1d6024ef092923321e6efd441b8d476db70aed
ToppCell	Healthy_donor-B_intermediate\|Healthy_donor / disease group, cell group and cell class (v2)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.60e-08	193	109	8	e2be57bf3cbbbbff64853f06b9c11b136f73eea7
ToppCell	severe_COVID-19-B_intermediate\|World / disease group, cell group and cell class (v2)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.71e-08	194	109	8	cb346cb186fe80a8f490ae90b2539b3543ba0ca9
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AMPD1 AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	2.71e-08	194	109	8	9b134a6e51b8556a04c362967fa474f8a7f59920
ToppCell	Healthy/Control-B_intermediate\|Healthy/Control / Disease group and Cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.71e-08	194	109	8	8a4260eeccb4924c392798b1ffa23cdd3a4062e9
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate\|Influenza_Severe / Disease, condition lineage and cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	3.17e-08	198	109	8	ab622fee61714471af3a7be0af356e8a484dcaff
ToppCell	Control-Control-Lymphocyte-B-B_intermediate\|Control / Disease, condition lineage and cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	3.30e-08	199	109	8	ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SCEL BLK CD22 IGHG3 IGHG4 GEN1 C13orf42	8.52e-08	149	109	7	2cd860b96ed4be4d26844085d464961c1418054a
ToppCell	ICU-SEP-Lymphocyte-B-B_intermediate\|ICU-SEP / Disease, Lineage and Cell Type	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	2.18e-07	171	109	7	2e44bf6f3d90193e7cadcac48bb852bd632a81bc
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.18e-07	171	109	7	a2938e56cb5749004317798dc7ac0f0c2d4d8ae0
ToppCell	Influenza_Severe-B_intermediate\|Influenza_Severe / Disease group and Cell class	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	2.45e-07	174	109	7	4276bdaac53aebd3084323a90ecde572d3177446
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RAB11FIP1 BLK CD22 IGHG3 ITSN2 GEN1 TPD52	2.45e-07	174	109	7	ebe6ce173ad12d4a2afa39f8d6185c0e4f97fb1e
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC26A3 CPA3 TEC NDC80 SYTL3 DSCC1 GEN1	2.65e-07	176	109	7	1f8d5a48fedbb4c86272c9b5a0f1ef573350357b
ToppCell	mild_COVID-19_(asymptomatic)-B_memory\|World / disease group, cell group and cell class (v2)	ANK3 NEXMIF AFF3 BLK CD22 IGHG3 IGHG4	2.75e-07	177	109	7	057871e211c6508b2a679d391f3cf0ac7ccfc628
ToppCell	CTRL-Lymphoid-B_cell\|CTRL / Disease state, Lineage and Cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	2.97e-07	179	109	7	dd4055c0a8360ea10323ef6249519a6ae08fc05a
ToppCell	COVID-19_Moderate-B_intermediate\|World / disease group, cell group and cell class	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	3.08e-07	180	109	7	bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7
ToppCell	severe_influenza-B_memory\|severe_influenza / disease group, cell group and cell class (v2)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	3.20e-07	181	109	7	92e572c92109a6dae0f73138c57c3bbd2e0a2f36
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	3.20e-07	181	109	7	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	Control-Lymphoid-B\|World / Disease state, Lineage and Cell class	AFF3 PLEKHA6 BLK CD22 IGHG3 IGHG4 TPD52	3.20e-07	181	109	7	9124f1a610cfc3355ad87921cd3eb5346956475d
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 BLK CD22 IGHG3 IGHG4 ITSN2 TPD52	3.20e-07	181	109	7	0bc58c8942491e7ee5b858c5742770df7677532f
ToppCell	(2)_B_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	AMPD1 AFF3 BLK CD22 IGHG3 IGHG4 TPD52	3.32e-07	182	109	7	8fe9b3a82159a388ffb642ac4f6aff05b8b5f944
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	3.32e-07	182	109	7	9c120ddd109103ef6fac9c32b84d16a7624d0580
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	3.45e-07	183	109	7	82fe14fc7039415de41bdfd615a1380bed99f560
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	3.45e-07	183	109	7	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	Healthy/Control-B_memory\|World / Disease group and Cell class	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	3.58e-07	184	109	7	9e1879d86b535ede9b47deb0752e291f987a5d5e
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	3.58e-07	184	109	7	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	3.58e-07	184	109	7	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	3.71e-07	185	109	7	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	tumor_Lung-B_lymphocytes\|tumor_Lung / Location, Cell class and cell subclass	AMPD1 AFF3 BLK CD22 IGHG3 IGHG4 TPD52	3.85e-07	186	109	7	a54b368d7921185c583e35b532a6898c5486c2fc
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	3.85e-07	186	109	7	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	3.85e-07	186	109	7	d7d884ff4184636081c350d29f797bd923c6a3b4
ToppCell	severe_influenza-B_intermediate\|severe_influenza / disease group, cell group and cell class (v2)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	3.99e-07	187	109	7	d6db8595aa72fdabc4a056ba6ce09876868a66d5
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	4.14e-07	188	109	7	18d16e3f095a109b6a690f46fe7fcd5674c3636b
ToppCell	Healthy/Control-B_memory\|Healthy/Control / Disease group and Cell class	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	4.14e-07	188	109	7	3aff07f77b2b15e7a30e47b30115178abe64474e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	4.29e-07	189	109	7	2b53dae0e6e85b7139f8a9872fbebb3705b2f1bf
ToppCell	CF-Lymphoid-B_cell\|CF / Disease state, Lineage and Cell class	AFF3 CCDC141 BLK IGHG3 IGHG4 GEN1 TPD52	4.44e-07	190	109	7	374d8fd63c733178acab07682ed1519693efab45
ToppCell	Healthy_donor-B_memory\|Healthy_donor / disease group, cell group and cell class (v2)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	4.44e-07	190	109	7	46104a521f00d399315deca86699cb261b2795d6
ToppCell	COVID-19_Severe-B_intermediate\|World / disease group, cell group and cell class	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	4.60e-07	191	109	7	f226fd69a26124ba98e4544f550b89a08e6a3708
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	4.94e-07	193	109	7	7cc10e8b51091869d46e462f3214999e7b5348b1
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 RAB11FIP1 KRT23 PPARGC1A OCLN SDC1 TPD52	4.94e-07	193	109	7	ee91a796d0f6d4cee7a93a525689e716fdceeda5
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	5.11e-07	194	109	7	2b61023a602d336ed0de174e9141046173db34e6
ToppCell	Control-Lymphoid-Plasma,_B_cells\|Control / Condition, Lineage and Cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	5.11e-07	194	109	7	31fff4361ebed6308b1e6b2b705ee6e0a695bd0c
ToppCell	COVID-19_Mild-Lymphoid_B-B_intermediate\|COVID-19_Mild / Disease group, lineage and cell class	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	5.11e-07	194	109	7	bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	5.11e-07	194	109	7	f2486b19ac52a48d19f80b38a5536bee3dad745b
ToppCell	PBMC-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	5.11e-07	194	109	7	7dbedbdece4271e10134c9338c85cb3e04484c75
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NSF AFF3 RAB11FIP1 CCDC141 BLK CD22 GEN1	5.11e-07	194	109	7	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	PBMC-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	5.11e-07	194	109	7	bd2c53fb064edfec76abe56a9ffaced0bda32ab0
ToppCell	Healthy-B_intermediate\|Healthy / disease group, cell group and cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	5.11e-07	194	109	7	aabee48bf689367edae2079b4b90d253715f1097
ToppCell	PBMC-Convalescent-Lymphocyte-B\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	5.29e-07	195	109	7	07852aab50a2ece9938334301f0a9d7181da06b8
ToppCell	Sepsis-Bac-SEP-Lymphocyte-B-B_intermediate\|Bac-SEP / Disease, condition lineage and cell class	ANK3 BLK CD22 IGHG3 IGHG4 DZIP3 TPD52	5.48e-07	196	109	7	1611920211beb1a3691e3853e0314792a74279a0
ToppCell	PBMC-Convalescent-Lymphocyte-B\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	5.48e-07	196	109	7	5e5928fc218859317860fc387928127ac8009ba8
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	AMPD1 AFF3 BLK CD22 IGHG3 IGHG4 TPD52	5.67e-07	197	109	7	88b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCell	mild_COVID-19-B_intermediate\|mild_COVID-19 / disease group, cell group and cell class (v2)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	5.67e-07	197	109	7	f669500120646f69355a6f920b892a6f2faeab63
ToppCell	severe_COVID-19-B_intermediate\|severe_COVID-19 / disease group, cell group and cell class (v2)	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	5.67e-07	197	109	7	3ba64850b344cb24a4d20d64392a0b2752950d40
ToppCell	mild_COVID-19-B_intermediate\|World / disease group, cell group and cell class (v2)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	5.67e-07	197	109	7	e909b898b7458071f176b6c04356ea3540589153
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B\|COVID-19_Severe / Disease, condition lineage and cell class	AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	5.86e-07	198	109	7	1831a777dd996c25f637d551d754ec1b9c23feb2
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B AFF3 SCEL FCHO2 CCDC141 STK33 OCLN	6.06e-07	199	109	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate\|COVID-19_Mild / Disease, condition lineage and cell class	AFF3 CCDC141 BLK CD22 IGHG3 GEN1 TPD52	6.06e-07	199	109	7	1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PAG1 BARD1 SMC2 NDC80 DSCC1 USP1 TOP2B	6.06e-07	199	109	7	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B-B_memory\|Influenza_Severe / Disease, condition lineage and cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	6.06e-07	199	109	7	bf0285f68c9cb1417fc070abc3cb224d07407e0e
ToppCell	Sepsis-ICU-SEP-Lymphocyte-B-B_intermediate\|ICU-SEP / Disease, condition lineage and cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4 TPD52	6.06e-07	199	109	7	160b0f9687a996c4fea2a1a66f225af386483951
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-B_intermediate\|COVID-19_Severe / Disease, condition lineage and cell class	AFF3 BLK CD22 IGHG3 IGHG4 GEN1 TPD52	6.06e-07	199	109	7	ad3c369a67926725917b771094f82ca6dd2af783
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ZGRF1 BARD1 SMC2 NDC80 DSCC1 USP1 GEN1	6.27e-07	200	109	7	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	COVID-19-COVID-19_Convalescent-Lymphocyte-B\|COVID-19_Convalescent / Disease, condition lineage and cell class	AFF3 BLK CD22 IGHG3 IGHG4 SDC1 TPD52	6.27e-07	200	109	7	dfd3a2d84022cd9ae52a8182b36a9064940a56af
ToppCell	mild-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AFF3 CCDC141 BLK CD22 ITSN2 GEN1 TPD52	6.27e-07	200	109	7	fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 CCDC141 BLK CD22 STK33 TPD52	9.82e-07	134	109	6	8707210b2a5d33baa1d204e9e2ed8921181cb309
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1	1.49e-06	144	109	6	fca32b38d23fa4d213e553b929604a2796e9a929
ToppCell	10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory\|Lung / Manually curated celltypes from each tissue	AFF3 CCDC141 BLK CD22 IGHG3 GEN1	2.66e-06	159	109	6	d3202ddc291b8686dbe67690df13c7daffec2199
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1	2.76e-06	160	109	6	7ad065337ac802de52c15ee715f6b78a3eed0cef
ToppCell	Adult-Immune-B_cell-D231\|Adult / Lineage, Cell type, age group and donor	AMPD1 AFF3 BLK CD22 IGHG3 IGHG4	3.07e-06	163	109	6	4f5821299b265663c7d0352b28285f56e1988841
ToppCell	Influenza_Severe-B_memory\|Influenza_Severe / Disease group and Cell class	AFF3 CCDC141 BLK CD22 IGHG3 IGHG4	3.29e-06	165	109	6	51172acaeb667b34b8b8c7878d67cfa0c4a2dffc
ToppCell	Bronchial_Brush-Immune-B_cells\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	AMPD1 AFF3 CCDC141 BLK CD22 IGHG3	3.78e-06	169	109	6	dc388f660f69e37e517bf3243daf071ab138ee6e
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZGRF1 BARD1 SMC2 NDC80 DSCC1 GEN1	3.78e-06	169	109	6	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	URO-Lymphocyte-B-B_intermediate\|URO / Disease, Lineage and Cell Type	AFF3 BLK CD22 IGHG3 IGHG4 TPD52	3.91e-06	170	109	6	e11d1510518cedabeece96d4adbb90999e6326fa
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Basophil\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TDRD5 SLC26A3 CPA3 TEC TBC1D4 SYTL3	3.91e-06	170	109	6	bca78719c17355772ad6c53ee75e459faf1d089f
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TDRD5 SLC26A3 CPA3 TEC TBC1D4 SYTL3	3.91e-06	170	109	6	40d863554ec98ae43f76511c1112859688846613
ToppCell	Children_(3_yrs)-Immune-B_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AFF3 BLK CD22 IGHG3 IGHG4 TPD52	3.91e-06	170	109	6	e421f9eedf74baffda1d03707a710ece4b777f29
ToppCell	ICU-NoSEP-Lymphocyte-B-B_intermediate\|ICU-NoSEP / Disease, Lineage and Cell Type	BLK CD22 IGHG3 IGHG4 INPP5J TPD52	4.04e-06	171	109	6	c6b8578577aef4fe79c1a8ca778a068052f2c9d4
ToppCell	Influenza_Severe-B_intermediate\|World / Disease group and Cell class	BLK CD22 IGHG3 IGHG4 GEN1 TPD52	4.04e-06	171	109	6	4d33e1dc1efc423dbdd5f4cca6d6440a68add8d0
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BARD1 SMC2 NDC80 DSCC1 ANAPC5 ZNF287	4.18e-06	172	109	6	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	Control-Lymphoid-B_Plasma\|Control / Disease state, Lineage and Cell class	AMPD1 BLK IGHG3 IGHG4 SDC1 TPD52	4.18e-06	172	109	6	61e33836b8cb0f347f3e699eb587a37073b6fa4c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	UNC13B ANK3 SCEL CCDC141 STK33 OCLN	4.32e-06	173	109	6	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	mild_COVID-19_(asymptomatic)-B_memory\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	ANK3 NEXMIF BLK CD22 IGHG3 IGHG4	4.32e-06	173	109	6	9082ad77b44f65b72094df6e502cce81b62fe81a
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZGRF1 SMC2 MEIOSIN DSCC1 USP1 GEN1	4.47e-06	174	109	6	66555c610251ea04f968c258e312d720c18e7cde
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	AFF3 BLK CD22 IGHG3 IGHG4 GEN1	4.62e-06	175	109	6	1b3510e9078eec7cfc5805043e435e9e5e0f0877
ToppCell	Adult-Immune-B_cell\|Adult / Lineage, Cell type, age group and donor	AMPD1 BLK CD22 IGHG3 IGHG4 TPD52	4.77e-06	176	109	6	4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d
Disease	Muscle AMP deaminase deficiency	AMPD1 AMPD3	1.25e-05	2	105	2	C0268123
Disease	Adenosine monophosphate deaminase deficiency	AMPD1 AMPD3	1.25e-05	2	105	2	C2931781
Disease	serum IgG measurement	AFF3 FCHO2 IGHG3	3.44e-05	18	105	3	EFO_0004565
Disease	tyrosine-protein kinase TEC measurement	TEC TEC	7.49e-05	4	105	2	EFO_0020830
Disease	nephrotic syndrome (implicated_via_orthology)	KIRREL3 FAT1 ITSN2	8.39e-05	24	105	3	DOID:1184 (implicated_via_orthology)
Disease	pontocerebellar hypoplasia (implicated_via_orthology)	AMPD1 AMPD3	1.25e-04	5	105	2	DOID:0060264 (implicated_via_orthology)
Disease	Parkinson's disease (implicated_via_orthology)	FOXO3 NSF PPARGC1A NUS1 VPS13A	2.52e-04	157	105	5	DOID:14330 (implicated_via_orthology)
Disease	inducible T-cell costimulator measurement	IGHG3 NUS1	2.60e-04	7	105	2	EFO_0021967
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	AFF3 TEC BLK TEC TPD52	3.63e-04	170	105	5	EFO_0000685, EFO_0007791, EFO_0007837
Disease	parental longevity	PAG1 NRP1 CEMIP PPARGC1A VPS13A ADGRE5 ZNF287 ANAPC4	3.94e-04	494	105	8	EFO_0007796
Disease	waist-hip ratio	FOXO3 AMPD3 ANK3 AFF3 COL5A3 ACTRT2 SCEL NRP1 CEMIP PBRM1 NISCH POC5 ARHGAP21	4.16e-04	1226	105	13	EFO_0004343
Disease	Malignant neoplasm of breast	FLNA SPTAN1 BARD1 PKDREJ PBRM1 NISCH ITSN2 OSBPL11 OCLN GKN1 ANAPC5 GEN1	4.42e-04	1074	105	12	C0006142
Disease	seasonality measurement	TJP2 SDC1	8.09e-04	12	105	2	EFO_0006876
Disease	waist circumference	FOXO3 DAB1 SMARCAD1 SLC10A2 KAT8 MEIOSIN POC5	8.76e-04	429	105	7	EFO_0004342
Disease	brain volume measurement	FOXO3 AMPD3 NSF ACTRT2 VIT KATNA1 SLC10A2 SH3PXD2A	1.31e-03	595	105	8	EFO_0006930
Disease	rheumatoid arthritis	AFF3 TEC BLK SH3PXD2A TEC ANAPC4 TPD52	1.34e-03	462	105	7	EFO_0000685
Disease	obesity (biomarker_via_orthology)	FOXO3 ACACB PPARGC1A SDC1	1.91e-03	147	105	4	DOID:9970 (biomarker_via_orthology)
Disease	cystathionine measurement	TEC TEC	2.06e-03	19	105	2	EFO_0010474
Disease	albumin:globulin ratio measurement	AFF3 FCHO2 BLK	2.27e-03	73	105	3	EFO_0005128
Disease	mucocutaneous lymph node syndrome	DAB1 BLK TPD52	2.55e-03	76	105	3	EFO_0004246
Disease	epilepsy (implicated_via_orthology)	UNC13B RIPK1 NSF NUS1	2.78e-03	163	105	4	DOID:1826 (implicated_via_orthology)
Disease	complex trait	VIT CCDC141 KAT8 CHD6 USP1	2.88e-03	271	105	5	EFO_0010578
Disease	electrocardiography	DAB1 PLEKHA6 CCDC141 CEMIP PPARGC1A CLPB SH3PXD2A	2.91e-03	530	105	7	EFO_0004327
Disease	small cell lung carcinoma	FCHO2 NRP1 STK33	2.95e-03	80	105	3	EFO_0000702
Disease	spermatogenic failure (is_implicated_in)	USP26 C2CD6	3.02e-03	23	105	2	DOID:0111910 (is_implicated_in)
Disease	Cleft palate, cleft lip	VAX1 CEMIP SH3PXD2A PDP1 POC5	3.26e-03	279	105	5	EFO_0003959, HP_0000175
Disease	thyroxine measurement	ZGRF1 PPARGC1A KIRREL3	3.27e-03	83	105	3	EFO_0005130
Disease	brain stem volume measurement	FOXO3 KATNA1	3.29e-03	24	105	2	EFO_0010605

Protein segments in the cluster

Peptide	Gene	Start	Entry
YFNEDRKISPQSKES	TDRD5	701	Q8NAT2
KNSKPNELESVYSGD	USP26	631	Q9BXU7
IDYFKNSSKAAQAPS	AFF3	1091	P51826
PKNYSNTSKIFSEEN	ANAPC4	146	Q9UJX5
KDASAQQDSYEFVSP	BARD1	171	Q99728
APSAEANQKKYFVGE	ACTRT2	46	Q8TDY3
DKSKDFYPFGSNVQS	ADGB	21	Q8N7X0
EGYSIKPETNQNDTK	FCHO2	321	Q0JRZ9
GYEPVSGAKTFKNES	ADGRE5	96	P48960
TPKKYSQFSADVAEA	C13orf42	141	A0A1B0GVH6
RFDKFNDKYNPVGAS	AMPD1	371	P23109
GTFPYDDGSKQEIKN	CEMIP	821	Q8WUJ3
FDKFNSKYNPVGASE	AMPD3	386	Q01432
SNYVKPKDQESFGSA	ITSN2	1031	Q9NZM3
SSNGKVNDKRFYPES	OCLN	326	Q16625
PDSAYKTAQAVKDFN	ACACB	2131	O00763
QVASAASYDQPKKAE	ANAPC5	671	Q9UJX4
KSYTNVPADDVSGNK	RSPH10B	646	P0C881
KSYTNVPADDVSGNK	RSPH10B2	646	B2RC85
DNASPKFTSKEYSVE	FAT1	1661	Q14517
AGIDSTNNKKEEYGP	POC5	376	Q8NA72
AKNAKTYNEPGSQVF	PBRM1	256	Q86U86
TYNEPGSQVFKDANS	PBRM1	261	Q86U86
YAEKGTNKTNFTSIP	KCND1	346	Q9NSA2
YFSKEKESPDGNNVA	KAT8	301	Q9H7Z6
TKNNKPLYSFEDNAD	DYNC1I2	511	Q13409
PEVNKQRESYSGKFT	C2CD6	576	Q53TS8
KYSPEFANSNDKDDQ	NUS1	166	Q96E22
PSASINNDYFEDLKK	PGM2	221	Q96G03
RDPGSKKDYSQYEEN	KRT23	111	Q9C075
FLQKKSIDSNPYDTD	NSF	101	P46459
NFSKVEDYQLPDAKT	PARP4	591	Q9UKK3
LNYKTEEPASDKGSE	TMEM63A	726	O94886
AYTQEAPQEKDTASK	MEIOSIN	406	C9JSJ3
ANEYSFKVPEFDGKN	PDP1	91	Q9P0J1
KNLKYPGENDQSFSG	DZIP3	296	Q86Y13
SNSDDFDPASTKSKY	PPARGC1A	766	Q9UBK2
KAKSFEGNNNYDTPE	NRP1	536	O14786
PDLVKEFNKYDTDGS	ACTR3	236	P61158
NQSSYNFTVKEEDPG	CDHR2	696	Q9BYE9
YSVNPNKVDDLSKFG	GKN1	121	Q9NS71
KKAVGAFSVTYDPEN	FMR1	151	Q06787
NYRGSAPESEKETKA	CPA3	271	P15088
PYEGPDSQKEKDSNS	DSCC1	146	Q9BVC3
NKTSDSFLNYPSDKV	CCDC141	966	Q6ZP82
KSQPVSNGYSFEDFE	DAB1	236	O75553
SQDYPGKYSEEESKS	CHD6	2041	Q8TD26
AKSPFEVYVDKSQGD	FLNA	366	P21333
ENKQTLSSGEKYDPD	GAN	336	Q9H2C0
DSEYTAQEGAKFPIK	BLK	386	P51451
AKTKSYFPESQNDVG	ANK3	4261	Q12955
YFPESQNDVGKQSTK	ANK3	4266	Q12955
SSDEQSAPVFGKAKY	GEN1	801	Q17RS7
KDPTNGYYSVNTFKE	KIRREL3	631	Q8IZU9
KSNAGADAETKEPKY	KIAA1210	1601	Q9ULL0
EPETNKFDSTGYDKD	KATNA1	176	O75449
GDDFSSVYKTAKEQG	CLPB	196	Q9H078
NAKTKPREEQYNSTF	IGHG3	216	P01860
NAKTKPREEQFNSTY	IGHG4	166	P01861
YTTSKFNDAEPAKGN	CFAP47	1471	Q6ZTR5
KKFSYVDADGSPVNV	COL5A3	1616	P25940
STIKPYNAEDNENFK	CZIB	81	Q9NWV4
NPEYNKNTSKFDGTR	CD22	61	P20273
YKNGADQPFATDQSK	OSBPL11	306	Q9BXB4
KENGTEPESSFYKAN	SLC10A2	326	Q12908
ENNSISSIPEKYFDK	OMD	241	Q99983
KDYPKNTEEEFSGVN	MMP20	426	O60882
QPSDSYAQDQGKFIS	OR2G3	261	Q8NGZ4
VPYFKDKGDSNSSAG	FOXO3	191	O43524
KFDKGDNSSQQDPAT	RTL4	151	Q6ZR62
KAEKYEDSVPQSNGE	SYTL3	436	Q4VX76
CKKQDYSPSSGEAQE	RAB11FIP1	711	Q6WKZ4
EKQSTAYEKQFPATS	STK33	446	Q9BYT3
AYEKQFPATSKDNFD	STK33	451	Q9BYT3
PSYSQKSEDDSAKFD	TOP2B	1451	Q02880
KRKASGSENEGDYNP	TOP2B	1546	Q02880
TPDNERKASISYFKN	SMARCAD1	71	Q9H4L7
DDQYTSSSGAKFPVK	TEC	516	P42680
PGYNEDSRSTFFDKK	NEXMIF	1416	Q5QGS0
KQAIDESTNGFTYKP	PKDREJ	1846	Q9NTG1
KDEGSYSLEEPKQAN	SDC1	281	P18827
YSTSKFNPSQEKDGK	SLC26A3	726	P40879
VNAKPTEKSDVYSFA	RIPK1	201	Q13546
NDLYATVKDFEKTPN	PAG1	356	Q9NWQ8
PTFKFDVGTNKYDTS	INPP5J	656	Q15735
GSNEPKANYEQSKKD	PLEKHA6	721	Q9Y2H5
NLAFVKNDSYEKGPD	USP19	281	O94966
PKAKTQNKEESYDFS	TJP2	996	Q9UDY2
KSYEYKSNPSAVAGN	TJP2	1011	Q9UDY2
FSVSDDFQEYNKPGK	ZC3H6	241	P61129
YEKDGSASPAVTKDQ	VPS13A	1341	Q96RL7
KSDKAQSGPYNVEKE	ZNF287	21	Q9HBT7
LYKPDSNEFAVGTKN	SAGE1	776	Q9NXZ1
PYTSQSKDEIGFEKG	SH3PXD2A	276	Q5TCZ1
ENSKSPKDGYQENIS	SCEL	586	O95171
ATDEAYKDPSNLQGK	SPTAN1	596	Q13813
EPVDKDFYSEFGNKT	NISCH	1286	Q9Y2I1
KSPAAQAGETTKAYQ	VIT	156	Q6UXI7
AKFQGSPDKFNTYVT	UNC13B	11	O14795
QPGDDVVSNYFTKGK	TEX261	156	Q6UWH6
YNPESEQDKNEKKGS	YTHDC1	31	Q96MU7
PNSAYDFKTNNPKEA	SMC2	951	O95347
AKPSKDNEDAFYNSQ	TBC1D4	186	O60343
TDAVYGDNKEDANKP	ZGRF1	651	Q86YA3
KDFSPKNVIYDDSSQ	ZNF140	86	P52738
DYQSPFDFDAGVNKS	TPD52	11	P55327
QPNSKTERSKSYDEG	ARHGAP21	871	Q5T5U3
YNKASNPDKVASTAF	USP1	681	O94782
PDSDAYNSGDDKNEK	ZC3H13	846	Q5T200
FEPYSRTNNKEGAEK	VAX1	316	Q5SQQ9
EYNSNDGKKLPQGES	L1TD1	151	Q5T7N2
EFSAGTVYPETNKTK	N4BP1	396	O75113
NSKGYDFEIKFNPEA	NDC80	431	O14777